Adimmune

Adimmune Biotech Corporation(4142) is determined and committed to continue developing the COVID-19 vaccine

Adimmune Biotech Corporation pointed out, after receiving the government's official notificatio

Prepared for the international markets Adimmune Biotech Corporation appointed Dr. Chun Cheng Chen as the Chief Medical Officer

Adimmune Biotech Corporation(4142) announced today, beginning January 2021 Dr. Chun

Adimmune COVID-19 Vaccine Production Team Welcomes JHL Biotech, Inc

Adimmune Biotech Corporation(4142) announced today that it has signed a Master Service Agreemen

Adimmune Biotech Corporation’s COVID-19 vaccine entered the human clinical test phase. Taiwan’s unlocking from the epidemic is to be expected in the near future

Adimmune Biotech Corporation’s(4142) COVID-19 vaccine entered Phase 1 human clinical test this

Adimmune Biotech Corporation signed a $4.2 billion syndicated loan agreement, the sufficient funds would invigorate the company’s future business expansion

Adimmune Biotech Corporation(4142) secured a $4.2 billion syndicated loan today. Adimmune Chair

Adimmune Biotech Corporation applied permit for COVID-19 vaccine human clinical experiment

Adimmune Biotech Corporation(4142) held its 2020 shareholders meeting today. In the meeting it

During a visit to Adimmune Biotech Corporation(4142), Executive Yuan Premier Cheng Chang Su expressed his high expectations for the company’s success in developing the COVID-19 vaccine

Today, the Executive Yuan Premier Cheng Chang Su and his administrative team visited Adimmune B

Adimmune visited by Executive Yuan, promises to deliver COVID-19 vaccine

Adimmune Biotech Corporation(4142), today welcomed the scie

COVID-19 Epidemic drives demand for influenza vaccine

Adimmune Biotech Corporation(4142) April revenue came in at

COVID-19 Vaccine proven effective, Adimmune COVID-19 vaccine antibody response is excellent

When the COVID-19 epidemic first broke out in January 2020,

Adimmune’s new COVID-19 vaccine clinical trials confirms vaccine effectiveness

Adimmune Biotech Corporation(4142) announced today, Adimmun

Adimmune strives to turn losses into profit this year, as profit margins turn from negative to positive

Adimmune Biotech Corporation(4142) announced today that rev

AIT visit Adimmune

Adimmune production line expansion on schedule and will accelerate COVID-19 vaccine development

Adimmune Biotech Corporation(4142), announced today that Fe

Adimmune collaborates with the Taiwanese National Health Research Institute to accelerate research for Covid-19 vaccine

In order to assist the government in handling COVID-19, the

Adimmune Corporation monthly revenue hits new historical record again

Adimmune Biotech Corporation(4142), announced today that mo

Adimmune Board of Directors passes plan to construct new factory Initiating the construction of “All purpose biotech campus”

Adimmune(4142) Board of Directors passed a plan on January

Adimmune December revenue soars, Signs contract abroad

Adimmune's Quadrivalent Flu Vaccine Approved by TFDA

TAIPEI,Taiwan, May 10

Adimmune begins shipments to EU and Phase III trial in Europe

TAIPEI,Taiwan, Nov. 23, 2016 /PRNewswir